Charlotte Schubert (@schubertcm) writes for GeekWire about the legacy of cellular therapy company Juno Therapeutics (now a Bristol Myers Squibb company) on the Seattle biotech scene (and beyond). The Seattle company launched in 2013, bolstering the region’s reputation as a cellular therapy powerhouse and opening the floodgates of capital investment in subsequent life sciences companies, which thrived on the expertise, leadership and relationships originally cultivated by Juno.
Search the site
Recently on NWscience.org
Upcoming events
- N/A, April 24, 2024 – April 30, 2024 – Women in Tech Regatta
- N/A, April 26, 2024 – April 29, 2024 – City Nature Challenge 2024
- N/A, April 28, 2024 – MIT Environmental Solutions Journalism Fellowship Applications Close